Dendritic cells (DCs) exhibit considerable heterogeneity in their anatomical location, surface phenotype, and functional properties. In this study, we demonstrate that peripheral lymph nodes contain at least four major, functionally separable, and independently derived, DC subsets, which can be clearly demarcated by their CD11c, CD40, and CD8 expression pattern. Surprisingly, all DCs derived directly from the bone marrow, the myeloid-and the lymphoid-related subsets, turned over fast with t 1/2 of a couple of days. In contrast, DCs exported from the skin, both dermal and epidermal, accumulated 3-to 4-fold slower, turnover that is dramatically increased by cutaneous inflammation.
D endritic cells (DCs)
2 are a heterogeneous group of APCs sharing characteristic morphology, expression of certain cell surface molecules, and the capability to efficiently activate T cells (1, 2) . The diversity of DCs within the lymphoid organs has been ascribed to either different, developmentally regulated, DC lineages and/or to distinct maturation stages of DCs (3) . However, the issue remains still partially unresolved.
To date, two different lineages of mouse DCs have been proposed. The majority of DCs, defined as myeloid-derived DCs, originate in the bone marrow from a common myeloid cell precursor, and are widely distributed in both lymphoid and nonlymphoid tissues (4) . Furthermore, DCs have been observed to develop also from two early T cell precursor populations and have, therefore, been termed lymphoid-related DCs (5, 6) . In addition to the common DC surface markers mentioned above, this DC subset is characterized by expression of the CD8␣␣ homodimer. The majority of CD8
ϩ DCs are found in the thymus, but the subpopulation is also present in the periphery (7) .
In the skin, two types of DCs have been described: Langerhans cells (LCs) usually located in the suprabasal regions of epidermis, and dermal DCs located primarily in the perivascular areas of the superficial plexus in the dermis (8) . The current knowledge about DCs in dermatology derives mainly from studies performed with epidermal LCs in normal and diseased skin (9, 10) . Less is known about the function of dermal DCs, but the observation that LCs are able, but not absolutely required to induce contact sensitivity suggests the participation of this second skin-residing DC population in T cell-mediated immune responses in the skin (11) .
A lot of experimental work has attempted to correlate the different DC subsets with distinct biological functions. Because thymic CD8
ϩ DCs are involved in negative selection (12) , it has been suggested that peripheral lymphoid-related CD8 ϩ DCs may also play a critical role in tolerization of T cells to self Ags by inducing T cell anergy or deletion (13) (14) (15) . However, two recent studies suggest that both DC subsets can prime CD4
ϩ T cells and differentially regulate Th1/Th2 priming in vivo (16, 17) . Moreover, CD8
ϩ DCs are also able to prime protective CTL responses in vivo, indicating that CD8
ϩ DCs are not a particular DC subset involved only in the maintenance of tolerance (18) .
To further elucidate the DC heterogeneity, we compared DCs obtained from different lymphoid organs in terms of surface marker expression, migratory properties, in vivo turnover, and presenting capacities. The staining with two mAbs, one specific for the integrin CD11c and the second for the CD40 molecule, in combination with the CD8␣-specific Ab, allowed us to demonstrate the presence of at least four putative DC subsets in the peripheral lymph nodes (LNs), whereas in the other organs analyzed (spleen, thymus, Peyer's patches, and also gut-associated LN), only two were detectable. In this study, we present the detailed analysis of these subpopulations with respect to their in vivo behavior as well as to their functional characteristics.
Materials and Methods

Mice
Except where indicated, all experiments were performed with BALB/c mice. BALB/c and C57BL/6 mice were provided by IFFA-Credo (Saint Germain-sur-l'Abresle, France). Transgenic mice expressing a MHC class I-restricted TCR specific for the peptide p33 derived from lymphocytic choriomeningitis virus (LCMV) (327), a MHC class II-restricted TCR specific for the OVA peptide 323-339 (DO11.10), a MHC class II-restricted TCR specific for moth cytochrome c (AD10), and the transgenic mouse line 107.1 expressing an I-E d transgene under the control of a segment of the I-E MHC class II promoter have been described previously (19 -22) . Mice were bred under specific pathogen-free conditions according to Swiss federal law.
DC isolation and phenotypic characterization
DCs were isolated from spleens, thymus, Peyer's patches, mesenteric LNs, and peripheral LNs (inguinal, popliteal, axillar, auricular) of BALB/c mice, as previously described (23) . Briefly, tissues were digested twice for 30 min at 37°C in IMDM supplemented with 5% FCS and 100 g/ml collagenase D (Boehringer Mannheim, Mannheim, Germany) in a shaking water bath. Cells were recovered, resuspended in a Optiprep gradient, and centrifuged at 600 ϫ g for 15 min. Low density cells in the interface were harvested and incubated for 30 min on ice with PE-labeled anti-CD11c and Cy5-labeled anti-CD40, washed, and sorted with a FACStar Plus (Becton Dickinson, Mountain View, CA), or analyzed using a FACScalibur (Becton Dickinson) excluding propidium iodide-positive dead cells. Sorted DC subsets were immobilized for 5 min onto poly(L-lysine)-coated coverslips and subsequently processed according to standard protocols. Briefly, the specimens were fixed with glutaraldehyde (2.5% v/v in 0.1 M sodium cacodylate buffer, pH 7.4) for 2 h at 25°C, incubated with osmium-tetroxide (1% w/v in double-distilled water) for another 1 h at 4°C, and dehydrated with acetone. Epon sections (80 nm) were poststained with aqueous uranyl-acetate and lead citrate (30 and 3 min, respectively) and examined with a transmission electron microscope at 60 kV (JEM 1200 EX, JEOL, Tokyo, Japan).
Skin organ culture
Ear skin from BALB/c mice was split in dorsal and ventral halves and cultured in 24-well culture plates (one ear/well), as previously described. Purified skin DCs were obtained by collecting the cells emigrating from these skin explants into the culture medium during 3 consecutive days and by sorting MHC class II-positive cells using a FACStar
Plus .
Three-color FACS analysis
To determine the phenotype of the different LN DC subsets, DC were isolated as described above, and stained for 30 min on ice with FITClabeled anti-CD11c, Cy5-labeled anti-CD40, and PE-labeled anti-B7-1, anti-B7-2, anti-I-A, anti-F4/80, anti-CD4, and anti-CD8␣. For the detection of E-cadherin and mannose-like receptor, DCs were stained with PE-labeled anti-CD11c, Cy5-labeled anti-CD40, and FITC-labeled anti-NLDC145 or purified rat anti-E-cadherin (Sigma, St. Louis, MO). After washing, FITClabeled goat anti-rat was added and cells were incubated for another 30 min on ice. Cells were washed, resuspended, and analyzed using a FACScalibur flow cytometer excluding propidium iodide-positive cells.
Kinetics of DC subsets in peripheral LN and in skin
Mice were injected i.p. with 1 mg bromodeoxyuridine (BrdU) (Sigma) dissolved in PBS and were fed thereafter with drinking water containing 1 mg/ml BrdU. DCs were isolated from peripheral LNs and skin explants and sorted, as described above. The purified cells were fixed subsequently overnight with 70% ethanol, washed with PBS, and resuspended in 0. 
In vitro immunostimulation assays
For the MLR, the MHC class II-and class I-restricted presentation assays, DCs were sorted using a FACStar Plus , as described above, obtaining a purity Ͼ97%. Ϫ8 M LCMV-derived peptide p33, washed five times, and cocultured with purified CD8 ϩ T cells obtained from LCMV-specific TCR-transgenic mouse. T cell proliferation was assessed by [ 3 H]thymidine (1 Ci/well) uptake in a 16-h pulse after 4 days for the MLR and 2 days for MHC class II-and class I-restricted presentation assay.
In vivo skin sensitization
Green fluorescent Cell Tracker (Molecular Probes, Leiden, The Netherlands) was dissolved 1:20 in a 50/50 (v/v) acetone-butyl phtalate mixture just before application. Mice were painted with 400 l on the shaved abdomen or with 50 l on the dorsal site of the ears. At different time points (1-4 days), draining LNs were collected and DC were isolated as described above. Cells were double stained with PE-labeled anti-CD11c and Cy5-labeled anti-CD40 and analyzed using a FACScalibur excluding propidium iodide-positive cells.
LCMV-derived peptide p33 or moth cytochrome c peptides (1 mg/ml DMSO) were dissolved 1:10 in a 50/50 (v/v) acetone-dibutyl phtalate mixture just before application. C57BL/6 and 107.1 mice, respectively, were painted with 50 l on the dorsal site of the ears. One, two, and three days after treatment, DC were isolated from draining LNs, as described above, stained with and sorted on the basis of different CD11c and CD40 expression patterns obtaining a purity of Ͼ97%. The same DC subsets were isolated and sorted from peripheral LNs of untreated mice. Purified DC (10 4 /well) were cocultured with purified CD8 ϩ T cells obtained from LCMV-specific TCR-transgenic mouse or with purified CD4 ϩ T cells obtained from moth cytochrome c-specific TCR-transgenic mouse (AD10), respectively, for 2 days and [
3 H]thymidine (1 Ci/well) for 16 h prior harvesting.
Results
Peripheral LNs contain several major DC subsets
Differential CD11c/CD40 expression pattern of gradient-enriched DCs revealed at least three potential DC subpopulations in the peripheral LNs: CD11c high CD40 int (I; ϳ18% of total DC population), CD11c int CD40
high (II; ϳ40% of total DC population), and CD11c high CD40
high (III; ϳ15% of total DC population) subsets with different cell size and granularity (not shown). Because the CD11c int CD40
negative subset does not share the morphological and functional properties of the other three DC subsets (I-III) (data not shown), we excluded that these cells belong to classical DCs and were not further characterized in this study.
When other lymphoid tissues were analyzed, such as spleen, Peyer's patches, thymus, and gut-associated mesenteric LNs, both CD11c int CD40
high (II) and CD11c high CD40 high (III) subsets were missing (Fig. 1B) , suggesting that these two subsets might be skinderived DCs. Only some scattered cells were found in the area of gates II and III, but they represent less than 2-3%.
We then further characterized these DC subsets with respect to several additional cell surface molecules by using three-color analysis for the expression of B7-1, B7-2, MHC class II, CD4, CD8␣, NLDC145, and F4/80 (Fig. 2) . All three subpopulations were positive for MHC class II and for both costimulatory molecules, B7-1 and B7-2, although with varying intensity. CD8␣, a marker found on lymphoid-related DCs, was highly expressed on more than 50% of high (III) subsets were negative for this molecule. In addition, in disagreement with recently published data, we were never able to detect an up-regulation of the CD8 molecule on fractions II and III upon skin irritation (see below) (24) . The CD4 molecule, known to be expressed on a subset of myeloid DC, was detectable only on about 30% of cells from the fraction I, whereas subsets II and III were clearly negative. Expression of NLDC145 correlated with that of CD8␣ in the CD11c high (II), whereas fraction I was negative (Fig. 3A) . Ultrastructurally, LCs are characterized by unique cytoplasmatic organelles, the so-called Birbeck granules. For this reason, we analyzed the presence of these structures by transmission electron microscopy. As expected, all cells of populations CD11c (Fig. 3B) ; however, structures resembling Birbeck granules were very rare and strictly confined to population CD11c high CD40
high (III) (see insert).
T cell-stimulatory capacity of peripheral LN DC subpopulations in vitro
We next analyzed the stimulatory activity in vitro of sorted DC subsets in allogeneic MLR and in peptide MHC class I and II presentation assays, as illustrated in Fig. 4 . In all three assays, all DC subsets were highly efficient to prime allogeneic T cells (Fig.  4A) , OVA-specific CD4 ϩ T cells (Fig. 4B) , and p33-specific CD8 ϩ T cells (Fig. 4C) , respectively.
Turnover of DC subsets in peripheral LN and in skin
To estimate how quickly DC subpopulations turn over in the peripheral LN, unimmunized BALB/c mice were fed with BrdU for up to 28 days. At different time points over this period, BrdU incorporation was monitored by FACS analysis and the percentage of BrdU ϩ cells was calculated (Fig. 5A ). More than 80% (plateau level) of CD11c high CD40 int (I) cells were BrdU ϩ after 10 days of continuous labeling, indicating that this DC subset turns over in about 10 days with an influx of DCs, probably directly derived from the bone marrow, of more than 10% a day. When CD8 ϩ and CD8
Ϫ DCs in fraction I were sorted and analyzed separately, the lymphoid-related CD8
ϩ subset had about 30% faster turnover kinetics when compared with the myeloid-related DCs (Fig. 5B) .
Interestingly, there was a clear 3-day lag period before BrdU ϩ cells started to accumulate in II and III subsets after which 28 days were needed to reach the plateau, suggesting a turnover of ϳ1 mo ( Fig. 5A) . To determine the turnover dynamics of skin resident DCs, we performed skin organ cultures from groups of mice treated over a period of 28 days with BrdU. At various time points, ears were collected and treated for primary skin culture. Cells emigrating from the skin explants into the culture medium during 3 consecutive days were collected, sorted for MHC class II-positive cells, and stained with anti-BrdU Ab, as described above. As shown in Fig. 5C , the MHC class II ϩ cells obtained from skin explants show a turnover of about 1 mo, because at day 28 more than 75% of the cells were labeled with BrdU.
In vivo skin sensitization drives two distinct DC populations into the draining LN
To induce migration of skin-residing DC subpopulations, mice were painted with a skin irritant, a mixture of butyl phtalate and acetone (1:1), and DCs of the draining LN were monitored over a period of 4 days. Green fluorescent Cell Tracker was added to the irritant mixture to assess the skin origin of different DC subsets by analyzing the presence of green fluorescent cells in the draining LN using the FACS, as shown in Fig. 6 . One day after skin painting, the majority of green cells were detectable in the CD11c high CD40 high (III) subset (70%), whereas the CD11c int CD40
high (II) subpopulation reached the peak 1 day later. The presence of fluorescence cells was clearly still detectable at day 3 (about 30% of both subsets), but rapidly declined by day 4. No green fluorescent cells were detectable in the remaining fraction I.
Capacity of different DC subsets to induce T cell proliferation after cutaneous peptide challenge
The in situ ability of skin-derived DCs to take up immunogenic peptides and present them in vitro to Ag-specific T cells was measured by isolating DCs from draining LNs at various times after cutaneous application of peptides in the appropriate solvent (1-3 days after treatment). As expected, only the CD11c int CD40
high (II) and CD11c high CD40 high (III) subsets carried the peptide information, because they were the only DCs capable of stimulating peptide-specific CD4 ϩ and CD8 ϩ T cells, whereas CD11c high CD40 int (I) subpopulation was unable to present the skin-applied peptides (Fig. 7) . In the case of p33, the MHC class I-binding peptide, maximum T cell proliferation was induced using DCs obtained from the draining LN 24 h after skin painting. Stimulatory capacity dramatically declined 2 and 3 days after treatment (Fig. 7A ). Skin painting with a MHC class II-binding peptide revealed a more prolonged presentation capacity of the immigrated DCs. In fact, the cutaneously applied peptide was presented by CD11c int CD40 high (II) and CD11c high CD40
high (III) 1 and 2 days after skin treatment, while at day 3 the presentation ability was markedly reduced (Fig. 7B) .
Discussion
By using CD11c/CD40/CD8 markers, we have been able to clearly define several DC populations in peripheral LN and to show that these populations are highly dynamic even in normal unperturbed physiological conditions. Although our dual marker analysis (CD11c/CD40) could demarcate four obvious subsets, only three of them, I, II, and III, are made of classical DCs based on their morphology, surface markers, and their capacity to act as professional APCs. The CD8 expression pattern allowed us to divide the fraction I into two additional subsets, the CD8 ϩ lymphoid-and the CD8 Ϫ myeloid-related DCs. Several observations strongly suggest that two of these populations, II and III, are derived from skin. First, they are only present in LNs that drain skin and not, e.g., in thymus, spleen, Peyer's . B, Transmission electron microscopy of freshly isolated subsets (I-III) obtained from peripheral LNs. Electron micrographs (all magnifications, ϫ3,500; insert, magnification ϫ100,000). Small insert shows a putative Birbeck granule.
patches, and mesenteric LNs. Second, only cells of subsets II and III carry the cutaneously applied Ag or cellular dye. Interestingly, the cells in subset III occasionally carry Birbeck granules and express E-cadherin, both markers of epidermal LCs, thereby making them most likely direct descendants of LCs (25, 26) . The cells in subset II are derived most likely from dermis, as suggested by kinetic analysis (see later). These conclusions are supported by earlier observations, which have established the presence of two different DC compartments in the skin: LC restricted to the epidermis (27) and dermal DC localized in the perivascular area of the dermis (28, 29) . The observation that LCs are able (30), but not essential, to induce contact hypersensitivity suggested also the participation of dermal DCs in the regulation of skin immune reactions (31) . Unfortunately, the phenotypic characterization of mouse dermal DCs has been hampered to date by the lack of unique serological markers, unlike in human system, in which CD36 can be used as a typical marker for these cells (29) .
The third subset (I) contains cells that belong to both the classical myeloid-and lymphoid-related DCs in about equal proportions. Continuous BrdU-labeling experiments showed that this subset in toto turned over rapidly in about 10 days. When analyzed separately, the lymphoid-related CD8
ϩ subset had about 30% faster turnover kinetics than the myeloid-related DCs, and this was the case not only in peripheral LNs, but also in the spleen and mesenteric LNs, in which corresponding subsets followed identical kinetics (data not shown). If DCs do not divide in periphery as is commonly argued (32) , it is most likely the case that BrdU ϩ cells are direct migrants from the bone marrow.
The skin-derived subsets II and III turned over much slower and they required about 30 days to do so. Interestingly, both of these subsets showed a clear lag period of 3 days before the BrdU ϩ cells started to accumulate in the LNs. Therefore, it seems that these cells had a minimum of 3 days of transit time in the skin during their journey from the bone marrow to peripheral LNs. If all DCs that were seeded from the bone marrow to the skin behaved as a homogenous cohort of cells in transit to LNs, we would expect that DCs in the skin were fully labeled in about 3 days (ϭ lag period). This was, however, clearly not the case. DCs in the skin turned over very slowly (about 30 days) and, therefore, we want to postulate that only a fraction of skin DCs are mobile. Indeed, earlier observations have indicated that a large portion of skin DCs are in fact sessile, and hence need long periods (several weeks) to become labeled and to migrate out from the skin (33) .
Our results about LN DCs showing different origins and dynamics are in agreement with recent published data from Salomon et al. (34) . In fact, they identified three distinct populations of lymph node DCs (a myeloid-and a lymphoid-related DC subset, but only one skin-derived DC subset) that can be distinguished on the basis of phenotype, morphology, turnover, and Ag-uptake characteristics. However, we extended these observations by measuring the turnover kinetics over a long time period for all identified DC subpopulations under normal homeostasis and, in addition, we also determined the inflammatory triggered superkinetics for both skinderived DC subsets.
In fact, it is well known that exposure to inflammatory cytokines (e.g., TNF-␣ and IL-1) (35), as well as bacterial components (e.g., LPS) (36), induces a rapid DC mobilization from peripheral nonlymphoid tissues to the draining LN. When contact sensitizers, such as FITC, were cutaneously applied on shaved mouse skin, many green fluorescent DC could be isolated from draining LNs (37). In our hands, skin irritation increased dramatically the turnover rate of cells in subsets II and III with characteristic differences. When irritant was applied together with a cellular dye, it could be observed that already 1 day after application the representation of subset III sharply increased (from about 6 to 22% of all DCs) (data not shown), and at the same time the proportion of dye-positive cells within subset III enhanced to about 70% corresponding to 6-to 7-fold increase of normal influx rates. Skin painting triggered similar drastic changes in kinetics of cells in fraction II, but with 1-day delay of the peak influx. We attribute this delay of kinetics to the anatomical location of the skin precursor of these cells. Mobile epidermal LCs, future fraction III, have faster access to the irritant/dye mixture than deeper residing dermal DCs, which would then give rise to fraction II. The possibility that cells in fraction III would differentiate to cells in subset II is made unlikely by the fact that II compartment is about 3-fold larger than III in normal and irritated LNs, and hence cellular division would have to be invoked, of which there is no evidence. In addition, if the putative differentiation step occurred, we would expect to observe delayed onset of accumulation of BrdU ϩ cells into fraction II as compared with fraction III in continuous labeling analysis, but this was not the case.
Rapid influx of DCs into LNs after skin irritation was followed by an almost as quick disappearance of the labeled cells. After 3 days of the peak immigration, Cell Tracker ϩ DCs in both II and III fractions were hardly detectable. Most likely these DCs died in the LNs during this 3-day period (vs 30 days during normal homeostasis) because no DCs have been observed to leave LNs via efferent lymphatics (38) .
Thus, it seems that T cells have a 3-day window in peripheral LNs to encounter and screen DCs for their antigenic cargo taken in inflammatory skin lesions. To test this directly, we applied defined MHC class I-and II-binding peptides on the skin in the presence of the irritant solvent and then measured in vitro the Ag-presenting activity of different DC subsets from draining LNs various times after application. Consistent with our Cell Tracker analyses, only cells in fractions II and III showed activity with characteristic kinetic biases. Interestingly, a class I peptide was presented only for 1 day, while a class II peptide could be detected at least for 2 days. Most likely class I/peptide complexes have shorter t 1/2 than corresponding class II complexes (39) . In fact, it is a hallmark of a mature DC that their MHC class II molecules show increased stability (40, 41) . It is not clear, in the case of class II, whether the loss of presentation is due to the loss of class II/peptide complexes or to the loss by death of the actual presenting cells. In this respect, it would be interesting to study the issue whether the Ag-specific T cells in vivo can rescue DCs or prolong their life span because two previous reports seem to be contradictory (42, 43) .
Having been able to identify clear subsets of DCs in peripheral LNs, it is now important to study how these subpopulations are regulated and how do they contribute functionally to the immune system. high (II) and CD11c high CD40 high (III) subsets stimulate Ag-specific CD4 ϩ and CD8 ϩ T upon cutaneous Ag application. Fifty microliters of MHC class II-restricted peptide (moth cytochrome c) and MHC class I-restricted (p33) were topically applied at a concentration of 100 g/ml butyl phtalate:acetone solution. One, two, and three days upon Ag painting, DCs were isolated from the draining LNs and sorted, and the different subsets were cocultured with Ag-specific T cells.
Proliferation of CD8
ϩ T cells (A) and CD4 ϩ T cells (B) was assessed by [ 3 H]thymidine (1 Ci/well) uptake in a 16-h pulse after 3 days.
